USNA FY2025 SEC EDGAR DEF 14A #50 of 168 in industry

Usana Health Sciences Inc CEO pay ratio

The CEO earned $4.3M in FY2025 against median worker pay of $50,813 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
UT
Filing date
2026-04-07
Industry
Chemicals & Pharmaceuticals
Industry rank
#50/168

Data updated August 2026

Subscribe to Usana Health Sciences Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
85:1
Moderate (Scale: 0–1000:1)
CEO pay
$4.3M
Median worker
$50,813

Answer first

Usana Health Sciences Inc's FY2025 CEO total of $4.3M ranks #978 of 1,423 complete filings; its 85:1 pay ratio ranks #731. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $50,813. Industry placement uses the FY2025 SIC-28 peer cohort (# 50 of 168, 71st percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#978
$4.3M of 1,423 FY2025
Ratio rank
#731
85:1 of 1,423
Industry pct
71st
above the industry median pay ratio

How Usana Health Sciences Inc ranks nationally

Usana Health Sciences Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$4,319,105 31st percentile higher than 31% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Usana Health Sciences Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($4.3M) against pay ratio (85:1) for Usana Health Sciences Inc (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3477847.28104765.11273168317358600.921985518.839.6:152.6:165.5:178.4:191.3:1CEO total payPay ratio (CEO : median worker)Usana Health Sciences Inc, CEO total pay: 4319105 · Pay ratio (CEO : median worker): 85:1Usana Health Sciences IncAvient Corp, CEO total pay: 5818257 · Pay ratio (CEO : median worker): 85:1Avient CorpRepligen Corp, CEO total pay: 6114771 · Pay ratio (CEO : median worker): 82:1Repligen CorpSupernus Pharmaceuticals, Inc., CEO total pay: 15501556 · Pay ratio (CEO : median worker): 81:1Supernus Pharmaceuticals, Inc.Moderna, Inc., CEO total pay: 20029717 · Pay ratio (CEO : median worker): 89:1Moderna, Inc.Vertex Pharmaceuticals Inc / Ma, CEO total pay: 21144261 · Pay ratio (CEO : median worker): 80:1Vertex Pharmaceuticals Inc / Ma
Usana Health Sciences Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Usana Health Sciences Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Usana Health Sciences Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
85:1
FY2025
vs prior FY
+14:1
from FY2024 71:1
CEO $ YoY
+29%
$4.3M latest
Filings shown
5
FY2021–2025
Usana Health Sciences Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $3.9M - $48,624 80:1 -
2022 $3.7M -3.9% $47,910 78:1 -2:1
2023 $3.1M -16% $45,951 68:1 -10:1
2024 $3.3M +7.1% $47,149 71:1 +3:1
2025 $4.3M +29% $50,813 85:1 +14:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 896264, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
85:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$4.3M
Companies in Industry
168
vs. Industry Median
Above
#50 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Usana Health Sciences Inc: MID · MID$ pay ratio

Usana Health Sciences Inc's FY2025 ratio 85:1 ranks #50 of 168 Chemicals & Pharmaceuticals filers (71st percentile). the CEO earned 85× the median employee ($50,813) in FY2025.

Median employee $50,813 (PAR-MED); MID · MID$ stamps put about 85 median-wage years per CEO year.

CEO Total Pay

$4.3M

FY2025 Summary Compensation, below median

Pay Ratio

85:1

Near industry median

Usana Health Sciences Inc in the higher Chemicals & Pharmaceuticals third

Usana Health Sciences Inc's FY2025 ratio 85:1 ranks #50 of 168 Chemicals & Pharmaceuticals filers (71st percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Usana Health Sciences Inc's $4.3M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #978 and ratio rank #731 split - treat 85:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$4.3M
Median Employee Pay
$50,813
Pay Ratio
85:1
Filing Date
2026-04-07

Company Info

Ticker
USNA
CIK
896264
Industry
Chemicals & Pharmaceuticals
SIC Code
2833
State
UT
View SEC filings →
SEC EDGAR DEF 14A for CIK 896264, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Usana Health Sciences Inc's FY2025 ratio 85:1 ranks #50 of 168 Chemicals & Pharmaceuticals filers (71st percentile).

Read with Usana Health Sciences Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · MID$ · PAR-MED.

Pacific Biosciences Of California, Inc. · MID$

ABS(ceo_total_comp) peer at $4.3M (Δ $9K lighter vs Usana Health Sciences Inc); FLOOR · ELITE-MED vs this page's MID · MID$ · PAR-MED.
WEBTOON Entertainment Inc. · MID$

ABS(ceo_total_comp) peer at $4.3M (Δ $18K lighter vs Usana Health Sciences Inc); MODEST · HIGH-MED vs this page's MID · MID$ · PAR-MED.
MAGNACHIP SEMICONDUCTOR Corp · MID$

ABS(ceo_total_comp) peer at $4.3M (Δ $19K lighter vs Usana Health Sciences Inc); MODEST · HIGH-MED vs this page's MID · MID$ · PAR-MED.
Orasure Technologies Inc · MID$

ABS(ceo_total_comp) peer at $4.3M (Δ $32K lighter vs Usana Health Sciences Inc); MODEST · HIGH-MED vs this page's MID · MID$ · PAR-MED.
Avient Corp (SIC 28 pole)

Avient Corp stamps MID · MID$ nearest in-SIC by ABS(pay_ratio) to Usana Health Sciences Inc's MID filing.
National dual ranks · #978/#731

Usana Health Sciences Inc's FY2025 package sits #978 by CEO dollars and #731 by ratio under MID$ · MID.
Pay-equity trends · MID

Usana Health Sciences Inc's MID · PAR-MED stamps sit mid-band - pay-equity trends place the ratio against workforce pay.
Data sourced from SEC EDGAR DEF 14A for Usana Health Sciences Inc (CIK 896264), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.